NewsRoom Articles - Page 553 of 606

MondayApr 16, 2018 11:18 am

Medical Cannabis Payment Solutions (REFG) Enables Online Enrollment for Proprietary ‘Green’ Payment System

Strategy drives traffic to its website, as licensed dispensaries and other retailers seek access to the company’s comprehensive digital payment system Green is being offered to more than just medical marijuana retailers, available to the entire cannabis industry REFG’s integrated gateway Green system works with existing point-of-sale processing equipment Medical Cannabis Payment Solutions (OTC: REFG) makes it easy for licensed merchants and dispensaries of marijuana to sign up online for its proprietary and comprehensive Green payment processing system, a full scale financial program for state-legalized cannabis markets (http://cnw.fm/Sr7Pb). Green offers its Financial Crimes Enforcement Network (FinCEN) compliant system to not…

FridayApr 13, 2018 12:04 pm

Medical Cannabis Payment Solutions (REFG) Exceeds Expectations with New Online Applications

Clients now have the ability to sign up for REFG’s services through the company’s Take.Green website High demand for efficient, cannabis-focused banking solutions Simplifying the process of medical cannabis purchases for customers and merchants Medical Cannabis Payment Solutions (OTC: REFG) offers one-of-a-kind comprehensive card processing operations through its Take.Green website, which serves the state-sanctioned medical marijuana industry, and now the company provides the opportunity for merchants to sign up for its services online. Previously, REFG was only working with targeted establishments, but it now offers its services to the entire state-sanctioned medical cannabis industry. The interest and activity generated by…

FridayApr 13, 2018 11:09 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Expands Patented Drug Delivery Portfolio with New Breakthroughs

Novel drug delivery system scientifically proven to increase absorption, bioavailability and efficacy New U.S. patents awarded, strengthening company’s IP portfolio Wide variety of patent families with ranging applications Building off DehydraTECH™, its patented lipophilic drug delivery platform, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has received another new Notice of Allowance from the United States Patent and Trademark Office that protects the company’s processes for making specific compositions of matter for enhanced cannabinoid delivery (http://cnw.fm/yN7AQ). This latest announcement comes on the heels of Lexaria’s March 22, 2018, press release that announced its receipt of a Notice of Allowance for the…

ThursdayApr 12, 2018 1:50 pm

ChineseInvestors.com, Inc. (CIIX) Committed to the Education and Use of Cryptocurrency

Focusing on the initial vision of financial consulting to the Chinese-speaking community Recent developments in CIIX’s cryptocurrency media and educational services, cryptocurrency ATMs and cryptocurrency mining shared at MicroCap Conference Committed to continued real-time education regarding use of cryptocurrency ChineseInvestors.com, Inc. (OTCQB: CIIX) provides real-time market commentary, analysis and education-related services to the Chinese-speaking community. “The company endeavors to be on the cutting edge of blockchain technology and to stay ahead of the curve in an effort to continue to build shareholder value and increase revenues this year,” CEO Warren Wang stated in a news release (http://cnw.fm/J0kLL). As the company…

WednesdayApr 11, 2018 1:47 pm

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Provides Update on Bio-Cannabis Product Pipeline

Several proprietary products developed and ready to market in Canada, California and global markets Cannabis product sales expected to generate significant revenue Pivot’s IP portfolio includes global patents to cement its leading position in the cannabis industry On April 4, 2018, Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) published an update on the advancements of its industry-leading cannabis product pipeline (http://cnw.fm/37EFo). A newly developed 1% cannabidiol (CBD) oral micelle solution, created in collaboration with the company’s German technology partner, Solmic GmbH, is ready to market. The development of two topical creams using Pivot’s patented formulation and delivery systems…

WednesdayApr 11, 2018 12:18 pm

Net Element, Inc. (NASDAQ: NETE) Subsidiary Launches New Same-Day Funding Service

E-commerce market expected to grow from $2.3 trillion in 2017 to $4.88 trillion by 2021 Point-of-sale market expected to reach $116 billion by 2025 Net Element’s new service, Fast Pass Funding, reduces funding times to as little as three hours Global technology and value-added solutions group Net Element, Inc. (NASDAQ: NETE) announced on April 5, 2018, that its Unified Payments subsidiary has launched a same-day funding service, called Fast Pass Funding, through its proprietary Netevia platform (http://cnw.fm/p3oZg). Fast Pass Funding is just one of many value-added services available to merchants through Net Element’s Netevia platform. The Fast Pass Funding service will…

WednesdayApr 11, 2018 11:11 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Tech Promises Versatile Commercial Applications

DehydraTECH™ has been shown to improve the taste, smell, bioabsorption and bioavailability of high performance ingestible consumer products Lexaria is working to eliminate negative side effects and enhance the healthy benefits of a variety of bioactive compounds Research being conducted for healthier oral ingestion of vitamins, nicotine and opioids DehydraTECH™ is a unique enabling technology from Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) that increases the absorption rate of edible ingestion, delivering five to 10 times more of active ingredients than traditional edibles. This technology is not a competing technology but rather a complementary layer that provides a versatile range…

TuesdayApr 10, 2018 1:11 pm

Earth Science Tech, Inc. (ETST) on Course to Complete White Paper Studies in 2019

ETST will investigate combination drugs that combine a mineral element with full spectrum cannabinoid industrial hemp oil; it anticipates completion of white paper studies in early 2019, with clinical trials to follow Goal is to produce both an OTC nutraceutical product and a cannabinoid companion generic drug to fight the epidemic of opioid dependency Foundations Wellness Center reports that two million Americans are now addicted to opioids Earth Science Tech, Inc. (OTC: ETST) has set 2019 as the crucial year when the company anticipates completion of white paper studies and the start of human clinical trials to investigate the synergies…

TuesdayApr 10, 2018 12:25 pm

Pressure BioSciences Inc.’s (PBIO) New Products and Enhanced Sales Capabilities Drive Plans for Banner 2018

Record product sales growth reported for fourth quarter and full year 2017 Company has over 300 of its ultra-high pressure instruments in research labs worldwide 2017 revenue exceeded $2.2 million with just one field sales rep; company’s field sales force expanded to five with recent hires December 2017 acquisition of high pressure IP allows company to enter the biologics contract research services sector Newly-issued patents in Ultra Shear Technology (UST) address broad markets for stable, water-soluble nanoemulsions, including cannabinoids As scientific researchers who work with cellular material seek to uncover new potential for creating vaccines and drugs, counteracting harmful chemicals…

TuesdayApr 10, 2018 10:43 am

Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) Growing Patent Portfolio Enables Commercialization, Defense of DehydraTECH

LXRP recently received a new U.S. patent allowance for ‘composition of matter’ related to its DehydraTECH™ platform’s delivery of cannabinoids; based on past experience, company expects formal granting of patent within 100 days Company filed new U.S. patent application for use of DehydraTECH to improve the speed of absorption of active pharmaceutical ingredients through the skin; compared to other commercial formulations, LXRP product exhibited up to a 225 percent increase in permeability LXRP gets primary revenue through third party licensing fees related to its proprietary and patented intellectual property; goal is to partner with leading firms globally to deliver best-in-class…

News and publishing service for cannabis related companies

Contact us: 512.354.7000